Episode 30: A New Far-Out Trial: Welcome to Jupiter
The topic for our 30th episode is stolen from the headlines. We look at the much publicized Jupiter trial of C-Reactive Protein (CRP) and the use of a statin. We review the details, strengths and...
View ArticleEpisode 52: CRP - An important part of a Comprehensive Risk Profile or a...
Episode 52 goes back in time to look in more detail at what we talked about in episode 30; the whole issue of CRP measurement. Mike and James start at the "large" issue of intra-subject variability,...
View ArticleEpisode 53: CRP - An important part of a Comprehensive Risk Profile or a...
Episode 53 continues where we left with the whole CRP measurement or no measurement discussion. James and Mike start with the Reynolds Risk Score and show how even at the extremes of CRP, absolute...
View ArticleEpisode 54: CRP - An important part of a Comprehensive Risk Profile or a...
Episode 54 finishes off the whole issue of CRP measurement by looking at the evidence we have about what happens to patients when they take drugs that lower CRP - glitazones, COX-2s, fibrates, vitamin...
View ArticleEpisode 74: Vitamin A, B, C, NOT D, and E - not all letters are created equal
In episode 74, Mike (Bert) and James (Ernie), along with Tina (Betty Lou) continue their stroll down medical Sesame Street and take a look at the evidence behind Vitamins (Letters) A,B,C, and E. Lo and...
View ArticleEpisode 213: Questions that lead to questions and then more questions - Part II
In episode 213, James and Mike continue on their merry quest of answering the world’s problems. We discuss CRP, ibuprofen for pain, zoster vaccines, thiazides and risk calculators. The questions are...
View Article
